156 related articles for article (PubMed ID: 38444000)
1. Mesonephric-like adenocarcinoma of the ovary.
Yang Y; Zhao M; Jia Q; Tang H; Xing T; Li Y; Tang B; Xu L; Wei W; Zheng H; Shi R; Xia B; Chen J
J Ovarian Res; 2024 Mar; 17(1):57. PubMed ID: 38444000
[TBL] [Abstract][Full Text] [Related]
2. Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis.
Dundr P; Gregová M; Němejcová K; Bártů M; Hájková N; Hojný J; Stružinská I; Fischerová D
Diagn Pathol; 2020 Jul; 15(1):91. PubMed ID: 32693840
[TBL] [Abstract][Full Text] [Related]
3. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
McCluggage WG; Vosmikova H; Laco J
Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
[TBL] [Abstract][Full Text] [Related]
5. Mesonephric-like adenocarcinoma of the ovary: A case report and a review of the literature.
Chen Q; Shen Y; Xie C
Medicine (Baltimore); 2020 Nov; 99(48):e23450. PubMed ID: 33235131
[TBL] [Abstract][Full Text] [Related]
6. [Proliferative lesions with mesonephric features in the gynecologic tract: a clinicopathological analysis of sixteen cases].
Mo N; He CY; Yu HY; Bian XT; Jin YL
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):1000-1006. PubMed ID: 36207913
[No Abstract] [Full Text] [Related]
7. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract][Full Text] [Related]
8. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors.
Kim H; Na K; Bae GE; Kim HS
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829389
[TBL] [Abstract][Full Text] [Related]
9. Ovarian Combined Serous Borderline Tumor/Low-grade Serous Carcinoma and Mesonephric-like Lesion: Report of 2 Cases With New Observations.
Nilforoushan N; Liu L; Finkelman BS; Andersen J; Liu Y; James J; Hung CF; Wu TC; Vang R; Xing D
Int J Gynecol Pathol; 2023 Mar; 42(2):182-191. PubMed ID: 35348533
[TBL] [Abstract][Full Text] [Related]
10. A rare case of primary ovarian mesonephric adenocarcinoma and a review of the literature.
Canbey C; Ceylan EC; Demir I; Solak HT; Erel E; Aybek OY; Senol T
Ann Ital Chir; 2022 Mar; 11():. PubMed ID: 35348127
[TBL] [Abstract][Full Text] [Related]
11. Mesonephric-like adenocarcinoma of the ovary in an elderly woman: A case report and a review of the literature.
Ujita M; Abiko K; Kuwahara R; Emoto I; Amano Y; Konishi I
J Obstet Gynaecol Res; 2021 Dec; 47(12):4490-4495. PubMed ID: 34580958
[TBL] [Abstract][Full Text] [Related]
12. Primary mesonephric adenocarcinoma of the fallopian tube: A case report.
Xie C; Shen YM; Chen QH; Bian C
World J Clin Cases; 2021 Jun; 9(18):4741-4747. PubMed ID: 34222441
[TBL] [Abstract][Full Text] [Related]
13. Extrauterine Mesonephric-like Neoplasms: Expanding the Morphologic Spectrum.
Deolet E; Arora I; Van Dorpe J; Van der Meulen J; Desai S; Van Roy N; Kaur B; Van de Vijver K; McCluggage WG
Am J Surg Pathol; 2022 Jan; 46(1):124-133. PubMed ID: 34183523
[TBL] [Abstract][Full Text] [Related]
14. Mesonephric adenocarcinomas in female genital tract: A case series.
Xie C; Chen Q; Shen Y
Medicine (Baltimore); 2021 Sep; 100(35):e27174. PubMed ID: 34477176
[TBL] [Abstract][Full Text] [Related]
15. Co-Existing Ovarian Mucinous Cystadenocarcinoma with Mature Cystic Teratoma: A Rare Case Report.
Suwannarurk K; Thaweekul Y; Mairaing K; Poomtavorn Y; Piyawong W; Himakhun W; Bhamarapravatana K
J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S281-6. PubMed ID: 29927186
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study.
Pors J; Segura S; Chiu DS; Almadani N; Ren H; Fix DJ; Howitt BE; Kolin D; McCluggage WG; Mirkovic J; Gilks B; Park KJ; Hoang L
Am J Surg Pathol; 2021 Apr; 45(4):498-506. PubMed ID: 33165093
[TBL] [Abstract][Full Text] [Related]
17. Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus.
Montagut C; Mármol M; Rey V; Ordi J; Pahissa J; Rovirosa A; Gascón P; Mellado B
Gynecol Oncol; 2003 Aug; 90(2):458-61. PubMed ID: 12893219
[TBL] [Abstract][Full Text] [Related]
18. An unusual case of carcinoma with mesonephric-like features with a spindle cell component diagnosed on the Pap test of the uterine cervix: Cytomorphologic and immunophenotypic features and diagnostic pitfalls.
Besharati S; Liu-Jarin X; Chen X; Cimic A
Diagn Cytopathol; 2022 Nov; 50(11):E325-E329. PubMed ID: 35778908
[TBL] [Abstract][Full Text] [Related]
19. Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics.
Koh HH; Park E; Kim HS
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204416
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naïve women with high-grade epithelial cancers of Mullerian origin.
Kudlowitz D; Velastegui A; Musa F; Muggia F
Cancer Chemother Pharmacol; 2018 May; 81(5):847-851. PubMed ID: 29516152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
